Compumed Inc News Today

CompuMed, FireStarter Collaborate to Further Shared Vision of Saving ...

Mercurity Fintech (NASDAQ:MFH – Get Free Report) and CompuMed (OTCMKTS:CMPD – Get Free Report) are both small-cap business services companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, dividends, risk, valuation, institutional ownership and analyst recommendations. Risk and Volatility Mercurity Fintech has a […]

CompuMed, Inc. (OTCMKTS:CMPD – Get Free Report)’s share price fell 11.8% on Friday . The stock traded as low as $1.48 and last traded at $1.50. 6,115 shares were traded during trading, an increase of 251% from the average session volume of 1,740 shares. The stock had previously closed at $1.70. CompuMed Stock Down 11.8 […]

LOS ANGELES, CA / ACCESSWIRE / March 12, 2024 / CompuMed, a pioneer in remote diagnostic services for the Organ Donation and Transplant Industry, is now extending its cutting-edge Echo and ECG interpretation services to rural and regional hospitals. This strategic addition comes after decades of dedicated service an...

12.03.2024 - LOS ANGELES, CA / ACCESSWIRE / March 12, 2024 / CompuMed, a pioneer in remote diagnostic services for the Organ Donation and Transplant Industry, is now extending its cutting-edge Echo and ECG interpretation services to rural and regional hospitals. ...

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The

CompuMed, Inc. (OTCMKTS:CMPD – Get Free Report) was the recipient of a large decline in short interest in October. As of October 31st, there was short interest totalling 5,500 shares, a decline of 12.7% from the October 15th total of 6,300 shares. Based on an average daily trading volume, of 700 shares, the short-interest ratio […]

CompuMed, Inc. (OTCMKTS:CMPD – Get Free Report) was the target of a significant decrease in short interest in the month of October. As of October 31st, there was short interest totalling 5,500 shares, a decrease of 12.7% from the October 15th total of 6,300 shares. Based on an average daily volume of 700 shares, the […]

Techcyte, the world leader in AI-based cellular digital diagnostics, is pleased to announce a collaboration with CompuMed to enhance the digital manual review of available livers and kidneys for organ transplantation. As

CompuMed Integrates the Techcyte Digital Pathology Reviewing Platform ...